Molecular mechanisms of thiazide-like diuretics-mediated inhibition of the human Na-Cl cotransporter
- PMID: 40830368
- PMCID: PMC12365235
- DOI: 10.1038/s41467-025-62714-w
Molecular mechanisms of thiazide-like diuretics-mediated inhibition of the human Na-Cl cotransporter
Abstract
Thiazide-type and thiazide-like diuretics are structurally distinct first-line antihypertensive drugs that target the sodium-chloride cotransporter (NCC) in the kidney. Thiazide-like diuretics are reported to have better cardioprotective effects than thiazide-type diuretics, but whether this is due to differences in NCC-inhibition mechanisms, if there is any, remains unclear. To understand the molecular mechanisms of NCC inhibition by thiazide-like diuretics, we determine the structures of human NCC (hNCC) bound to two of the most widely used thiazide-like diuretics, chlorthalidone and indapamide, using cryogenic electron microscopy (cryo-EM). Structural analyses reveal shared features and distinctions between NCC-inhibition by thiazide-like and thiazide-type diuretics. Furthermore, structural comparisons allow us to identify polymorphisms in hNCC that have substantial differential effects on the potencies of specific thiazide-like and thiazide-type diuretics. Our work provides important insights into the molecular pharmacology of NCC and a blueprint for developing precision medicine to manage hypertension with thiazide-like and thiazide-type diuretics.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
-
- World Health Organization. Global report on hypertension: The race against a silent killer (World Health Organization, 2023).
-
- Messerli, F. H., Williams, B. & Ritz, E. Essential hypertension. Lancet370, 591–603 (2007). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
